Cylex ImmuKnow Assay Levels Are Lower in Lung Transplant Recipients With Infection

Journal of Heart and Lung Transplantation

Volumn 27, Issue 9, 2008, Pages 990-994

  Bhorade, Sangeeta M ^a   Janata, Kelli ^b   Vigneswaran, Wickii T ^a   Alex, Charles G ^c   Garrity, Edward R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Pulmonary and Critical Care Medicine   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AZATHIOPRINE; DACLIZUMAB; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BLOOD SAMPLING; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; FEMALE; GENDER; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADULT; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNITY; IMMUNOASSAY; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFECTION; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 50249141261     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.06.005     Document Type: Article

References (10)

1. Kowalski R., Post D., Schneider M.C., et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 17 (2003) 77-88
2. + peripheral blood T cells. Ther Drug Monitor 23 (2001) 354
3. Kowalski R.J., Post D.R., Mannon R.B., et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 82 (2006) 663-668
4. Cadillo-Chavez R., de Echegaray S., Santiago-Delphin E.A., et al. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay. Transplant Proc 38 (2006) 918-920
5. Lee T.C., Goss J.A., Rooney C.M., et al. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection. Clin Transplant 20 (2006) 689-694
6. Gautam A., Fischer S.A., Yango A.F., et al. Cell mediated immunity (CMI) and post-transplant viral infections-role of a function al immune assay to titrate immunosuppression. Int Immunopharmacol 6 (2006) 2023-2026
7. Gautam A., Morrissey P.E., Brem A.S., et al. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder. Pediatr Transplant 10 (2006) 613-616
8. Zeevi A., Husain S., Spichty K.J., et al. Recovery of functional memory T cells in lung transplant recipients following induction therapy with alemtuzumab. Am J Transplant 7 (2007) 475-479
9. Kerman R.H., Kimball P.M., Van Buren C.T., et al. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation 51 (1991) 338
10. Neylan J.F. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. Transplantation 65 (1998) 586